These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23260709)

  • 21. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.
    Akalin E; Dinavahi R; Dikman S; de Boccardo G; Friedlander R; Schroppel B; Sehgal V; Bromberg JS; Heeger P; Murphy B
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1261-7. PubMed ID: 17942771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pancreas allograft biopsies with positive c4d staining and anti-donor antibodies related to worse outcome for patients.
    de Kort H; Munivenkatappa RB; Berger SP; Eikmans M; van der Wal A; de Koning EJ; van Kooten C; de Heer E; Barth RN; Bruijn JA; Philosophe B; Drachenberg CB; Bajema IM
    Am J Transplant; 2010 Jul; 10(7):1660-7. PubMed ID: 20455878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.
    Behr TM; Feucht HE; Richter K; Reiter C; Spes CH; Pongratz D; Uberfuhr P; Meiser B; Theisen K; Angermann CE
    J Heart Lung Transplant; 1999 Sep; 18(9):904-12. PubMed ID: 10528753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
    Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation.
    Fedson SE; Daniel SS; Husain AN
    J Heart Lung Transplant; 2008 Apr; 27(4):372-9. PubMed ID: 18374872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA).
    Loupy A; Hill GS; Suberbielle C; Charron D; Anglicheau D; Zuber J; Timsit MO; Duong JP; Bruneval P; Vernerey D; Empana JP; Jouven X; Nochy D; Legendre CH
    Am J Transplant; 2011 Jan; 11(1):56-65. PubMed ID: 21199348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C4d staining of perioperative renal transplant biopsies.
    Haas M; Ratner LE; Montgomery RA
    Transplantation; 2002 Sep; 74(5):711-7. PubMed ID: 12352891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
    Frank R; Lal P; Kearns J; Molina MR; Wald JW; Goldberg LR; Kamoun M
    Am J Clin Pathol; 2016 Jan; 145(1):62-8. PubMed ID: 26712872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Mediated Rejection is not Associated with Worse Survival in Adherent Heart Transplant Patients in the Contemporary Era.
    Kim PJ; Cusi V; Cardenas A; Tada Y; Vaida F; Wettersten N; Chak J; Bijlani P; Pretorius V; Urey MA; Morris GP; Lin G
    medRxiv; 2023 Dec; ():. PubMed ID: 38106112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.
    Pearl MH; Nayak AB; Ettenger RB; Puliyanda D; Palma Diaz MF; Zhang Q; Reed EF; Tsai EW
    Pediatr Nephrol; 2016 Aug; 31(8):1341-8. PubMed ID: 27048228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation.
    Fedrigo M; Gambino A; Benazzi E; Poli F; Frigo AC; Tona F; Caforio AL; Castellani C; Toscano G; Feltrin G; Gerosa G; Thiene G; Angelini A
    J Heart Lung Transplant; 2011 Dec; 30(12):1381-8. PubMed ID: 21930398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
    Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C4d deposition in cardiac allografts correlates with alloantibody.
    Smith RN; Brousaides N; Grazette L; Saidman S; Semigran M; Disalvo T; Madsen J; Dec GW; Perez-Atayde AR; Collins AB
    J Heart Lung Transplant; 2005 Sep; 24(9):1202-10. PubMed ID: 16143234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
    Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP
    Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C4d detection and histological patterns in the diagnosis of antibody-mediated rejection after lung transplantation: a single-centre study.
    Ngo C; Danel C; Duong-Quy S; Dauriat G; Castier Y; Lortat-Jacob B; Mal H; Brugière O; Cazes A
    Histopathology; 2019 Jun; 74(7):988-996. PubMed ID: 30636056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
    Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
    Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.